38 related articles for article (PubMed ID: 2907288)
21. Antidepressants in panic disorder and agoraphobia.
Lydiard RB; Ballenger JC
J Affect Disord; 1987; 13(2):153-68. PubMed ID: 2960710
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
23. Serotonin and panic disorders: a review of clinical studies.
Norman TR; Burrows GD; Judd FK; McIntyre IM
Int J Clin Pharmacol Res; 1989; 9(2):151-7. PubMed ID: 2654037
[TBL] [Abstract][Full Text] [Related]
24. Serotonin in panic disorder and social phobia.
Sheehan DV; Raj BA; Trehan RR; Knapp EL
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():63-77. PubMed ID: 7911142
[TBL] [Abstract][Full Text] [Related]
25. Biology of anxiety.
Teicher MH
Med Clin North Am; 1988 Jul; 72(4):791-814. PubMed ID: 2836673
[TBL] [Abstract][Full Text] [Related]
26. Noradrenergic and serotonergic receptor system function in panic disorder and depression.
Heninger GR; Charney DS; Price LH
Acta Psychiatr Scand Suppl; 1988; 341():138-50. PubMed ID: 3048049
[TBL] [Abstract][Full Text] [Related]
27. Increased anxiogenic effects of caffeine in panic disorders.
Charney DS; Heninger GR; Jatlow PI
Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
[TBL] [Abstract][Full Text] [Related]
28. Panic disorder: clinical perspectives.
Brandon S
J Psychiatr Res; 1993; 27 Suppl 1():11-21. PubMed ID: 7908329
[TBL] [Abstract][Full Text] [Related]
29. Serotonin and anxiety revisited.
Kahn RS; van Praag HM; Wetzler S; Asnis GM; Barr G
Biol Psychiatry; 1988 Jan; 23(2):189-208. PubMed ID: 3275471
[No Abstract] [Full Text] [Related]
30. The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis.
Andreatini R; Blanchard C; Blanchard R; Brandão ML; Carobrez AP; Griebel G; Guimarães FS; Handley SL; Jenck F; Leite JR; Rodgers J; Schenberg LC; Da Cunha C; Graeff FG
Braz J Med Biol Res; 2001 Feb; 34(2):145-54. PubMed ID: 11175489
[TBL] [Abstract][Full Text] [Related]
31. Peripheral indices of central serotonin function in humans.
Murphy DL
Ann N Y Acad Sci; 1990; 600():282-95; discussion 295-6. PubMed ID: 2252316
[No Abstract] [Full Text] [Related]
32. Neuropharmacology of anxiety: perspectives and prospects.
Hamon M
Trends Pharmacol Sci; 1994 Feb; 15(2):36-9. PubMed ID: 7909396
[No Abstract] [Full Text] [Related]
33. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM
Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
[TBL] [Abstract][Full Text] [Related]
34. Benzodiazepines in panic disorder and agoraphobia.
Sheehan DV
J Affect Disord; 1987; 13(2):169-81. PubMed ID: 2890678
[TBL] [Abstract][Full Text] [Related]
35. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Sheehan DV
Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
[TBL] [Abstract][Full Text] [Related]
36. Changes in the drug treatment of anxiety disorders.
Pohl R; Rainey JM; Gershon S
Psychopathology; 1984; 17 Suppl 1():6-14. PubMed ID: 6369369
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapeutic considerations in anxiety disorders.
Hollister LE
J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological treatment of panic disorder.
Judd FK; Norman TR; Burrows GD
Int Clin Psychopharmacol; 1986 Jan; 1(1):3-16. PubMed ID: 2881960
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
